Effects of SGLT2 inhibitors on systemic and tissue low-grade inflammation: The potential contribution to diabetes complications and cardiovascular disease
Diabetes & metabolism, 2018-12, Vol.44 (6), p.457-464 [Peer Reviewed Journal]2018 Elsevier Masson SAS ;Copyright © 2018 Elsevier Masson SAS. All rights reserved. ;ISSN: 1262-3636 ;ISSN: 1878-1780 ;EISSN: 1878-1780 ;DOI: 10.1016/j.diabet.2018.09.005 ;PMID: 30266577
Full text available